Cancer Biology and Medicine · 2021 · 31 citations · 27 references
MedicineCancer BiologyOncologyCarcinogenesisGene ExpressionMolecular OncologyNoncoding Rna BiologyNoncoding Rna FunctionNoncoding Rna In CancerRibosome BiogenesisSmall Nucleolar Rna BiologyTranslation RegulationMtor Pathway DysregulationPi3k-akt Signaling PathwayPi3k-akt-mtor SignalingPull-down AssaysRna ImmunoprecipitationRrna ModificationSmall Nucleolar Rna Dysregulation In DiseaseSmall Nucleolar Rna Function In Ribosome Biogenesis
Objective: The dysregulation of ribosome biogenesis is associated with the progression of numerous tumors, includinghepatocellular carcinoma (HCC). Small nucleolar RNAs (snoRNAs) regulate ribosome biogenesis by guiding the modification ofribosomal RNAs (rRNAs). However, the underlying mechanism of this process in HCC remains elusive. Methods: RNA immunoprecipitation and sequencing were used to analyze RNAs targeted by ribosome proteins. The biologicalfunctions of SNORA23 were examined in HCC cells and a xenograft mouse model. To elucidate the underlying mechanisms, the2′-O-ribose methylation level of rRNAs was evaluated by qPCR, and the key proteins in the PI3K/Akt/mTOR pathway were detectedusing Western blot. Results: Twelve snoRNAs were found to co-exist in 4 cancer cell lines using RPS6 pull-down assays. SNORA23 was downregulatedin HCC and correlated with the poor prognoses of HCC patients. SNORA23 inhibited the proliferation, migration, and invasionof HCC cells both in vitro and in vivo. We also found that SNORA23 regulated ribosome biogenesis by impairing 2′-O-ribosemethylation of cytidine4506 of 28S rRNA. Furthermore, SNORA23, which is regulated by the PI3K/Akt/mTOR signaling pathway,significantly inhibited the phosphorylation of 4E binding protein 1. SNORA23 and rapamycin blocked the PI3K/AKT/mTORsignaling pathway and impaired HCC growth in vivo. Conclusions: SNORA23 exhibited antitumor effects in HCC and together with rapamycin, provided a promising therapeuticstrategy for HCC treatment.
27
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sánchez-Vega, Marco Mina, Joshua Armenia et al. · Cell · 2018 · 3.4K citations · Full text
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Ruimei Feng, Yi‐Nan Zong, Su‐Mei Cao et al. · Cancer Communications · 2019 · 1.7K citations · Full text
Medicine, Oncology, Cancer Control +13
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui‐Hua Xu, Wei Wei, Michał Krawczyk et al. · Nature Materials · 2017 · 883 citations